These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38223588)

  • 1. Garlic supplementation for the treatment of chronic liver disease: a meta-analysis of randomized controlled trials.
    Xiaohui L; Jinqi L; Xiaofang X; Zhiqiang S; Renxiu N
    Afr Health Sci; 2023 Jun; 23(2):409-415. PubMed ID: 38223588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginger supplementation for the treatment of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Zhou Q; Peng Y; Chen F; Dai J
    Afr Health Sci; 2023 Mar; 23(1):614-621. PubMed ID: 37545930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empagliflozin for the treatment of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Tang X; Zhang H; Wang X; Yang D
    Afr Health Sci; 2022 Sep; 22(3):391-398. PubMed ID: 36910362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ
    Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
    Front Immunol; 2022; 13():949746. PubMed ID: 36159792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic outcome of dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Hu C; Qu T; Li L; Huang Y; Liu H; Rao C
    Afr Health Sci; 2023 Jun; 23(2):416-421. PubMed ID: 38223613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials.
    Goodarzi R; Sabzian K; Shishehbor F; Mansoori A
    Phytother Res; 2019 Mar; 33(3):561-570. PubMed ID: 30653773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and meta-analysis of the effect of garlic in patients with non-alcoholic fatty liver disease.
    Rastkar M; Nikniaz L; Abbasalizad Farhangi M; Nikniaz Z
    Indian J Gastroenterol; 2022 Dec; 41(6):548-557. PubMed ID: 36576698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of garlic supplementation on liver enzymes: A systematic review and meta-analysis of randomized controlled trials.
    Panjeshahin A; Mollahosseini M; Panbehkar-Jouybari M; Kaviani M; Mirzavandi F; Hosseinzadeh M
    Phytother Res; 2020 Aug; 34(8):1947-1955. PubMed ID: 32135032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Jalali M; Mahmoodi M; Mosallanezhad Z; Jalali R; Imanieh MH; Moosavian SP
    Complement Ther Med; 2020 Jan; 48():102283. PubMed ID: 31987259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of garlic supplementation on components of metabolic syndrome: a systematic review, meta-analysis, and meta-regression of randomized controlled trials.
    Fu Z; Lv J; Gao X; Zheng H; Shi S; Xu X; Zhang B; Wu H; Song Q
    BMC Complement Med Ther; 2023 Jul; 23(1):260. PubMed ID: 37481521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Guo XF; Wang C; Yang T; Li S; Li KL; Li D
    Food Funct; 2020 Sep; 11(9):7389-7399. PubMed ID: 32966467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soy diet for nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials.
    Xiong P; Zhu YF
    Medicine (Baltimore); 2021 Jun; 100(22):e25817. PubMed ID: 34087824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: results from a meta-analysis.
    Ji HF; Sun Y; Shen L
    Nutrition; 2014 Sep; 30(9):986-91. PubMed ID: 24976430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.
    He XX; Wu XL; Chen RP; Chen C; Liu XG; Wu BJ; Huang ZM
    PLoS One; 2016; 11(10):e0162368. PubMed ID: 27711128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional foods and dietary supplements in the management of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Wang LL; Zhang PH; Yan HH
    Front Nutr; 2023; 10():1014010. PubMed ID: 36866059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Nigella sativa in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Tang G; Zhang L; Tao J; Wei Z
    Phytother Res; 2021 Aug; 35(8):4183-4193. PubMed ID: 33728708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of garlic supplementation on oxidative stress markers: A systematic review and meta-analysis of randomized controlled trials.
    Moosavian SP; Arab A; Paknahad Z; Moradi S
    Complement Ther Med; 2020 May; 50():102385. PubMed ID: 32444050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials.
    Yan JH; Guan BJ; Gao HY; Peng XE
    Medicine (Baltimore); 2018 Sep; 97(37):e12271. PubMed ID: 30212963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.